Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

150 companies

Ticker	Company	Revenue	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS ▾
AGTX	Agentix Corp. Manufacturing · Year ended 2026-03-31 · USD	n/a	-$485.6K	n/a	n/a	n/a	-$0.01
VISK	Viskase Holdings, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$3.41M	n/a	n/a	n/a	-$0.07
CSBR	Champions Oncology, Inc. Manufacturing · Year ended 2026-04-30 · USD	$59.42M	-$1.18M	-2.0%	-29.8%	4.4%	-$0.08
PLX	Protalix BioTherapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$52.74M	-$6.60M	-12.5%	-13.7%	-1.2%	-$0.08
CPMV	Mosaic ImmunoEngineering Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$687.8K	n/a	n/a	n/a	-$0.10
IPSC	Century Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$109.16M	-$9.58M	-8.8%	-6.0%	n/m	-$0.14
GRML	Greenland Mines Ltd Manufacturing · Year ended 2025-12-31 · USD	n/a	-$10.55M	n/a	-111.5%	n/a	-$0.22
DYAI	Dyadic International Inc Manufacturing · Year ended 2025-12-31 · USD	$3.09M	-$7.36M	-238.3%	-597.6%	-11.6%	-$0.23
HUMA	Humacyte, Inc. Manufacturing · Year ended 2025-12-31 · USD	$2.04M	-$40.83M	n/m	n/m	n/a	-$0.26
LCTX	Lineage Cell Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$14.56M	-$63.53M	-436.5%	-146.6%	53.2%	-$0.28
IVVD	Invivyd, Inc. Manufacturing · Year ended 2025-12-31 · USD	$53.43M	-$52.49M	-98.2%	-21.7%	110.5%	-$0.30
PALI	Palisade Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$16.78M	n/a	-13.0%	n/a	-$0.30
CGTX	Cognition Therapeutics Inc Manufacturing · Year ended 2025-12-31 · USD	n/a	-$23.49M	n/a	-68.5%	n/a	-$0.32
FENC	Fennec Pharmaceuticals Inc. Manufacturing · Year ended 2025-12-31 · USD	$44.64M	-$9.74M	-21.8%	-27.5%	-6.1%	-$0.34
TSHA	Taysha Gene Therapies, Inc. Manufacturing · Year ended 2025-12-31 · USD	$9.77M	-$109.00M	n/m	-44.1%	17.3%	-$0.34
ESLA	Estrella Immunopharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$13.06M	n/a	n/a	n/a	-$0.35
IBRX	ImmunityBio, Inc. Manufacturing · Year ended 2025-12-31 · USD	$113.29M	-$351.40M	-310.2%	n/a	668.3%	-$0.38
ADPT	Adaptive Biotechnologies Corp Manufacturing · Year ended 2025-12-31 · USD	$276.98M	-$59.50M	-21.5%	-27.2%	54.8%	-$0.39
LIMN	Liminatus Pharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$10.21M	n/a	n/a	n/a	-$0.43
SGMOQ	Sangamo Therapeutics, Inc Manufacturing · Year ended 2025-12-31 · USD	$39.55M	-$122.93M	-310.8%	n/a	-31.6%	-$0.44
ELOX	Eloxx Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$6.00M	n/a	n/a	-100.0%	-$0.49
IKT	Inhibikase Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$48.26M	n/a	-27.9%	n/a	-$0.49
AVXL	Anavex Life Sciences Corp. Manufacturing · Year ended 2025-09-30 · USD	n/a	-$46.38M	n/a	-48.9%	n/a	-$0.54
CRIS	Curis Inc Manufacturing · Year ended 2025-12-31 · USD	$9.44M	-$7.58M	-80.3%	-138.8%	-13.4%	-$0.58
TNYA	Tenaya Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$90.60M	n/a	-73.5%	n/a	-$0.59

Rows per page: 2550 100